Evaluation of the Total Oxidant Status to the Antioxidant Capacity Ratio as a Valuable Biomarker in Breast Cancer Patients

سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 75

فایل این مقاله در 7 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RBMB-12-2_008

تاریخ نمایه سازی: 4 دی 1402

چکیده مقاله:

Background: The oxidative balance is a state of equilibrium between oxidants and antioxidants disrupted in various disorders, including BC. This study aimed to assess this equilibrium in breast cancer (BC) patients by looking at the oxidant-to-antioxidant ratio. Methods: This case-control study comprised ۴۰ women patients with breast cancer and ۳۰ age-matched healthy individuals. The oxidation-reduction colorimetric technique was used to determine serum levels of total oxidant status (TOS) and total antioxidant capacity (TAC). The oxidant-to-antioxidant balance was estimated using the TOS- to- TAC ratio (TOS/TAC). Results: The mean TOS in healthy individuals was ۸.۴۰±۲.۰۶ µmol/L, while in BC patients it was ۱۳.۳۱±۲.۱۶ µmol/L (P< ۰.۰۰۱). The mean serum level of TAC was ۱.۴۳±۰.۲۱ mmol/L in healthy individuals and ۱.۱۹±۰.۱۵ mmol/L in BC patients (P< ۰.۰۰۱). The mean serum TOS/TAC was ۶.۰۱±۰.۳۲ in the healthy individuals and ۱۱.۴۲±۰.۴۱ in the BC patients (P< ۰.۰۰۰۱). There were direct correlations between TAC and estrogen receptor (r=۰.۳۳۹, P=۰.۰۳۸). The TOS/TAC level has a sensitivity of ۱۰۰% and specificity of ۸۳.۳۳%, distinguishing patients with BC from healthy controls (P< ۰.۰۰۱). A significant trend of increasing risk with rising TOS/TAC levels was also seen [OR=۳.۶۲, (۹۵ % CI ۱.۷۹, ۷.۳۵)]. Conclusions: In breast cancer, the serum TOS to TAC ratio can better diagnose oxidative equilibrium than either component alone.

نویسندگان

Ahmad Ahmadzadeh

Firoozgar Clinical Research Development Center (FCRDC), Iran University of Medical Sciences, Tehran, Iran.

Mohammad Javad Khodayar

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Maryam Salehcheh

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Zahra Nazari Khorasgani

Nanotechnology Research Center, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

Mehrnoush Matin

Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran & Department of Toxicology, Faculty of Pharmacy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Mayeux R. Biomarkers: potential uses and limitations. NeuroRx. ۲۰۰۴;۱(۲):۱۸۲-۸ ...
  • Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, ...
  • Organization WH. Breast cancer now most common form of cancer ...
  • Hagag S, Kodous A, Shaaban HA. Molecular and Immunohistochemical Alterations ...
  • Toyokuni S. Oxidative stress as an iceberg in carcinogenesis and ...
  • Prasad S, Gupta SC, Pandey MK, Tyagi AK, Deb L. ...
  • Pilco-Ferreto N, Calaf GM. Influence of doxorubicin on apoptosis and ...
  • Erel O. A new automated colorimetric method for measuring total ...
  • Erel O. A novel automated direct measurement method for total ...
  • Wu R, Feng J, Yang Y, Dai C, Lu A, ...
  • Mahmood IH, Abdullah KS, Abdullah MS. Total antioxidant status in ...
  • Hammer C, Fanning A, Crowe J. Overview of breast cancer ...
  • El-Deeb MMK, El-Sheredy HG, Mohammed AF. The role of serum ...
  • Feng J-F, Lu L, Zeng P, Yang Y-H, Luo J, ...
  • Erten Şener D, Gönenç A, Akıncı M, Torun M. Lipid ...
  • Ray G, Husain SA. Role of lipids, lipoproteins and vitamins ...
  • Zarrini AS, Moslemi D, Parsian H, Vessal M, Mosapour A, ...
  • Zowczak-Drabarczyk M, Murawa D, Połom K, Szarszewska M, Nowakowski W, ...
  • Gupta RK, Patel AK, Kumari R, Chugh S, Shrivastav C, ...
  • Postovit L, Widmann C, Huang P, Gibson SB. Harnessing Oxidative ...
  • Mobley JA, Brueggemeier RW. Estrogen receptor-mediated regulation of oxidative stress ...
  • Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy DJ. ...
  • Didžiapetrienė J, Kazbarienė B, Tikuišis R, Dulskas A, Dabkevičienė D, ...
  • Wonisch W, Falk A, Sundl I, Winklhofer-Roob BM, Lindschinger M. ...
  • Hewala TI, Elsoud M. The clinical significance of serum oxidative ...
  • Badid N, Baba Ahmed FZ, Merzouk H, Belbraouet S, Mokhtari ...
  • نمایش کامل مراجع